Drug Profile
Research programme: antiviral therapeutics - Aphios
Alternative Names: Albasomes; APP-0303; APP-0401; Hypericin - Aphios; nanoHYPLatest Information Update: 28 Apr 2023
Price :
$50
*
At a glance
- Originator Aphios Corporation
- Class Antiretrovirals; Antivirals
- Mechanism of Action HIV replication inhibitors; Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV infections; Smallpox
Most Recent Events
- 28 Apr 2023 No recent reports of development identified for research development in HIV-infections in USA
- 08 Apr 2021 Early research development is still ongoing for HIV infections in USA (Aphios Corporation website, April 2021)
- 04 Nov 2017 No recent reports of development identified for preclinical development in HIV-infections in USA